Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
暂无分享，去创建一个
A. Borkhardt | C. Eckert | G. Henze | A. Barth | T. Klingebiel | R. Handgretinger | W. Holter | P. Bader | C. Peters | A. von Stackelberg | H. Kabisch | A. Willasch | K. Sykora | H. Kreyenberg | M. Reising